Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis
Amélie Dendooven(University of Antwerp), Roel Goldschmeding(University Medical Center Utrecht), Robbert J. Kok(Utrecht University), Tri Q. Nguyen(Utrecht University), Karin G. F. Gerritsen
Cited by 61
Related Papers
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285